The Man Trying to Cure ME/CFS & Long Covid: Prof. Klaus Wirth on Mitodicure
📅 Released for International ME/CFS Awareness Day
In this landmark interview, Prof. Klaus Wirth — one of the foremost researchers in ME/CFS and Long Covid — shares his groundbreaking mission: to develop Mitodicure, a drug that could become the first approved medication for ME/CFS and Long Covid.
Working with Prof. Carmen Scheibenbogen, Wirth has proposed a unifying biological model of ME/CFS — one that may finally explain post-exertional malaise (PEM), low blood volume, mitochondrial dysfunction, and more.
In this video, we discuss:
How Mitodicure works at a cellular level
What patients might expect when taking it
Where the drug is in the development process
Why raising awareness now could accelerate clinical trials
▶️ Please watch, share, and spread the word — Mitodicure could change everything.
📌 Tag media outlets, researchers, and advocates to help get this drug the attention it deserves.
📘 My New Book: Understanding ME/CFS & Strategies for Healing
Amazon: https://www.amazon.com/dp/2959831004
Other stores: https://books2read.com/u/bOk9J0
⏱️ Timestamps
00:00 Intro – Why This Interview Matters
06:25 Start of Interview
07:30 How Prof. Wirth First Encountered ME/CFS
09:00 Wirth’s Unique Scientific Approach
11:08 Why Does Low Blood Volume Happen in ME/CFS?
15:18 Why a Unifying Model of ME/CFS Is Crucial
18:22 Explaining Exercise-Induced Damage & the PEM Threshold
19:42 The Cellular Problem: Muscle Dysfunction in ME/CFS
24:42 Why Muscle Cell Death Matters in PEM
30:28 How Mitodicure Works (Mechanism of Action)
32:12 What Might Happen When a Patient Takes Mitodicure?
36:38 Why PEM Is the Key Target for Treatment
37:42 How Mitodicure Could Shift ME/CFS Research
39:32 Where Mitodicure Is in the Development Process
40:40 Final Words from Prof. Wirth
🔗 Resources Mentioned:
W&S unifying hypothesis - https://www.sciencedirect.com/science/article/pii/S1568997220300823
W&S accumulated evidence skeletal muscle disturbance - https://onlinelibrary.wiley.com/doi/full/10.1002/jcsm.13669
PEM muscle necrosis - https://www.nature.com/articles/s41467-023-44432-3
Mitodicure - www.mitodicure.com
Hvidberg - https://pubmed.ncbi.nlm.nih.gov/26147503/
Wirth previously on gez medinger channel (first in series of two) - https://www.youtube.com/watch?v=9gwMw69XCP0
🧠 Affiliates / Tools That Helped Me:
• Normalyte (ORS blood volume supplement): https://normalyte.com/?ref=ftveadx3
• DNRS Brain Retraining: https://retrainingthebrain.com/?wpam_id=219
🌐 My Website & Consultations:www.patrickussher.com
📩 Want to share your story on the channel?Contact me through the site above.
📕 Free eBook: The Myth of Primary Polydipsia in ME/CFS, POTS & Long Covid www.themythofprimarypolydipsia.com
⚠️ Disclaimer: This content is for educational purposes only and is not medical advice. Always consult a qualified healthcare professional before making health decisions.
#MEcfs
#LongCovid
#Mitodicure
#MECFSawareness
#PostExertionalMalaise
Видео The Man Trying to Cure ME/CFS & Long Covid: Prof. Klaus Wirth on Mitodicure канала Understanding ME-CFS
In this landmark interview, Prof. Klaus Wirth — one of the foremost researchers in ME/CFS and Long Covid — shares his groundbreaking mission: to develop Mitodicure, a drug that could become the first approved medication for ME/CFS and Long Covid.
Working with Prof. Carmen Scheibenbogen, Wirth has proposed a unifying biological model of ME/CFS — one that may finally explain post-exertional malaise (PEM), low blood volume, mitochondrial dysfunction, and more.
In this video, we discuss:
How Mitodicure works at a cellular level
What patients might expect when taking it
Where the drug is in the development process
Why raising awareness now could accelerate clinical trials
▶️ Please watch, share, and spread the word — Mitodicure could change everything.
📌 Tag media outlets, researchers, and advocates to help get this drug the attention it deserves.
📘 My New Book: Understanding ME/CFS & Strategies for Healing
Amazon: https://www.amazon.com/dp/2959831004
Other stores: https://books2read.com/u/bOk9J0
⏱️ Timestamps
00:00 Intro – Why This Interview Matters
06:25 Start of Interview
07:30 How Prof. Wirth First Encountered ME/CFS
09:00 Wirth’s Unique Scientific Approach
11:08 Why Does Low Blood Volume Happen in ME/CFS?
15:18 Why a Unifying Model of ME/CFS Is Crucial
18:22 Explaining Exercise-Induced Damage & the PEM Threshold
19:42 The Cellular Problem: Muscle Dysfunction in ME/CFS
24:42 Why Muscle Cell Death Matters in PEM
30:28 How Mitodicure Works (Mechanism of Action)
32:12 What Might Happen When a Patient Takes Mitodicure?
36:38 Why PEM Is the Key Target for Treatment
37:42 How Mitodicure Could Shift ME/CFS Research
39:32 Where Mitodicure Is in the Development Process
40:40 Final Words from Prof. Wirth
🔗 Resources Mentioned:
W&S unifying hypothesis - https://www.sciencedirect.com/science/article/pii/S1568997220300823
W&S accumulated evidence skeletal muscle disturbance - https://onlinelibrary.wiley.com/doi/full/10.1002/jcsm.13669
PEM muscle necrosis - https://www.nature.com/articles/s41467-023-44432-3
Mitodicure - www.mitodicure.com
Hvidberg - https://pubmed.ncbi.nlm.nih.gov/26147503/
Wirth previously on gez medinger channel (first in series of two) - https://www.youtube.com/watch?v=9gwMw69XCP0
🧠 Affiliates / Tools That Helped Me:
• Normalyte (ORS blood volume supplement): https://normalyte.com/?ref=ftveadx3
• DNRS Brain Retraining: https://retrainingthebrain.com/?wpam_id=219
🌐 My Website & Consultations:www.patrickussher.com
📩 Want to share your story on the channel?Contact me through the site above.
📕 Free eBook: The Myth of Primary Polydipsia in ME/CFS, POTS & Long Covid www.themythofprimarypolydipsia.com
⚠️ Disclaimer: This content is for educational purposes only and is not medical advice. Always consult a qualified healthcare professional before making health decisions.
#MEcfs
#LongCovid
#Mitodicure
#MECFSawareness
#PostExertionalMalaise
Видео The Man Trying to Cure ME/CFS & Long Covid: Prof. Klaus Wirth on Mitodicure канала Understanding ME-CFS
Комментарии отсутствуют
Информация о видео
12 мая 2025 г. 9:15:01
00:43:42
Другие видео канала